This page collects WhisperX intelligence signals tagged #Regulatory Policy. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.
Rivian has secured a pivotal legal and regulatory victory in Washington state, a move that directly challenges the entrenched franchise dealership model and signals a potential shift in how electric vehicles are sold across the United States. This win grants Rivian the authority to sell its vehicles directly to consume...
The U.S. Food and Drug Administration (FDA) is reportedly preparing to grant compounding pharmacies the authority to produce and dispense injectable peptide drugs. This potential policy shift represents a significant regulatory development for a class of substances that has surged in popularity for uses ranging from we...
The U.S. Food and Drug Administration is preparing to reverse a significant safety policy, moving to potentially allow compounding pharmacies to produce more than a dozen injectable peptides it had previously banned. These substances, removed from the approved compounding list in 2023, were flagged for 'potentially sig...
U.S. electricity prices are poised for significant near-term increases, driven by an unprecedented wave of rate hike requests from investor-owned utilities (IOUs). A joint analysis by Lawrence Berkeley National Laboratory and The Brattle Group reveals that revenue increase requests in 2025 have exceeded any point since...
A coalition of biotech investors and patient advocates has directly petitioned President Trump, urging the administration to push for greater regulatory flexibility at the Food and Drug Administration. The move signals mounting industry pressure to reshape the drug approval landscape, particularly for rare disease trea...